Benzinga's Top #PreMarket Gainers

Dendreon DNDN soared 9.37% to $3.15 in the pre-market trading after the company posted better-than-expected Q4 results and announced its plans to make PROVENGE available in Europe. Revance Therapeutics RVNC surged 9.54% to $29.50 in the pre-market session after dropping 10.05% on Friday. Perion Network PERI shares gained 8.44% to $12.98 in the pre-market on quarterly results. Randgold Resources GOLD shares jumped 4.30% to $82.40 in pre-market trading after falling 1.18% on Friday.